New agents in follicular lymphoma.

  title={New agents in follicular lymphoma.},
  author={Bruce D Cheson},
  journal={Best practice & research. Clinical haematology},
  volume={24 2},
The follicular lymphomas are indolent diseases that are highly responsive to various combinations of standard chemotherapy drugs. Nevertheless, until recently, no regimen had improved patient outcome. The incorporation of effective and well-tolerated monoclonal antibodies, such as rituximab, into chemoimmunotherapeutic strategies provided the first evidence… CONTINUE READING